Concord Biotech's US$650m Lock-Up Expiry - Some Could Be Tempted to Book Multi-Bagger Gains
Ontario is looking to raise US$56m from selling a 3.4% stake in Concord Biotech. The deal has a floor price of INR1,320/share, at a 8.5% discount...
511 Views
Swiggy Pre-IPO Early Look - Innovation Leader, Profitability Laggard
Swiggy aims to raise US$1.25bn in its upcoming India IPO. The company has filed confidentially for its IPO, which is likely to be launched towards...
392 Views
Aequitas 2024 Asia IPO Pipeline - India
In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.
467 Views
Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note
Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.
426 Views
Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
674 Views